ESMO 2026 Presentations Deepen the Evidence Base for Natera’s Oncology Portfolio and Leadership in Ultrasensitive MRD Technology

Go back to ESMO 2026 Presentations Deepen the Evidence Base for Natera’s Oncology Portfolio and Leadership in Ultrasensitive MRD Technology
(NASDAQ: NTRA) Delayed: 401.37 --0 (-0%)
Previous Close $401.37    52 Week High $13.80 
Open $401.37    52 Week Low $6.52 
Day High $401.37    P/E N/A 
Day Low $401.37    EPS $0.00 
Volume 341